JP2014514261A5 - - Google Patents

Download PDF

Info

Publication number
JP2014514261A5
JP2014514261A5 JP2013556793A JP2013556793A JP2014514261A5 JP 2014514261 A5 JP2014514261 A5 JP 2014514261A5 JP 2013556793 A JP2013556793 A JP 2013556793A JP 2013556793 A JP2013556793 A JP 2013556793A JP 2014514261 A5 JP2014514261 A5 JP 2014514261A5
Authority
JP
Japan
Prior art keywords
alkyl
ring atoms
heterocyclyl
het
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013556793A
Other languages
English (en)
Japanese (ja)
Other versions
JP6250403B2 (ja
JP2014514261A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/026874 external-priority patent/WO2012118782A1/en
Publication of JP2014514261A publication Critical patent/JP2014514261A/ja
Publication of JP2014514261A5 publication Critical patent/JP2014514261A5/ja
Application granted granted Critical
Publication of JP6250403B2 publication Critical patent/JP6250403B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013556793A 2011-02-28 2012-02-28 ヒストン脱アセチル化酵素阻害剤 Expired - Fee Related JP6250403B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161447416P 2011-02-28 2011-02-28
US61/447,416 2011-02-28
PCT/US2012/026874 WO2012118782A1 (en) 2011-02-28 2012-02-28 Histone deacetylase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017161679A Division JP2018012718A (ja) 2011-02-28 2017-08-24 ヒストン脱アセチル化酵素阻害剤

Publications (3)

Publication Number Publication Date
JP2014514261A JP2014514261A (ja) 2014-06-19
JP2014514261A5 true JP2014514261A5 (cg-RX-API-DMAC7.html) 2016-03-17
JP6250403B2 JP6250403B2 (ja) 2017-12-20

Family

ID=46758274

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013556793A Expired - Fee Related JP6250403B2 (ja) 2011-02-28 2012-02-28 ヒストン脱アセチル化酵素阻害剤
JP2017161679A Pending JP2018012718A (ja) 2011-02-28 2017-08-24 ヒストン脱アセチル化酵素阻害剤
JP2018242538A Pending JP2019065037A (ja) 2011-02-28 2018-12-26 ヒストン脱アセチル化酵素阻害剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017161679A Pending JP2018012718A (ja) 2011-02-28 2017-08-24 ヒストン脱アセチル化酵素阻害剤
JP2018242538A Pending JP2019065037A (ja) 2011-02-28 2018-12-26 ヒストン脱アセチル化酵素阻害剤

Country Status (9)

Country Link
US (1) US9540395B2 (cg-RX-API-DMAC7.html)
EP (2) EP3524324A1 (cg-RX-API-DMAC7.html)
JP (3) JP6250403B2 (cg-RX-API-DMAC7.html)
AU (2) AU2012223509B2 (cg-RX-API-DMAC7.html)
CA (2) CA2828524C (cg-RX-API-DMAC7.html)
DK (1) DK2680694T3 (cg-RX-API-DMAC7.html)
ES (1) ES2712803T3 (cg-RX-API-DMAC7.html)
PT (1) PT2680694T (cg-RX-API-DMAC7.html)
WO (1) WO2012118782A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2620027T3 (es) 2008-09-03 2017-06-27 Biomarin Pharmaceutical Inc. Composiciones que incluyen derivados del ácido 6-aminohexanoico como inhibidores de HDAC
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
CA2828524C (en) 2011-02-28 2020-01-07 Repligen Corporation Histone deacetylase inhibitors
US8957066B2 (en) * 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
EP2712655B1 (en) 2011-04-28 2019-12-18 The Broad Institute, Inc. Inhibitors of histone deacetylase
US9790184B2 (en) 2012-07-27 2017-10-17 The Broad Institute, Inc. Inhibitors of histone deacetylase
US9914717B2 (en) 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
BR112015023399A8 (pt) 2013-03-15 2019-12-03 Biomarin Pharm Inc inibidores de hdac, seu uso e composição farmacêutica
EP3769757A3 (en) * 2013-10-18 2021-10-06 The General Hospital Corporation Imaging histone deacetylases with a radiotracer using positron emission tomography
WO2016109549A1 (en) 2014-12-30 2016-07-07 University Of Utah Research Foundation Hdac1,2 inhibitors and methods of using the same
US11149062B2 (en) 2015-08-28 2021-10-19 Uwm Research Foundation, Inc. HDAC inhibitors and methods of treatment using the same
CN105920604B (zh) * 2016-06-08 2019-09-03 上海荻硕贝肯生物科技有限公司 用于治疗白血病的联合用药物及其在治疗白血病中的应用
CN106977474B (zh) * 2017-05-10 2020-04-07 四川大学 一种取代2-氰基-3-苯基呋喃-丙烯酰胺衍生物及其制备方法和用途
JP2021510733A (ja) * 2018-01-12 2021-04-30 ケーディーエーシー セラピューティクス，インコーポレーテッドＫｄａｃ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． がんの処置のための選択的ヒストンデアセチラーゼ３（ｈｄａｃ３）インヒビターと免疫治療剤との組み合わせ
GB201901559D0 (en) 2019-02-05 2019-03-27 Syngenta Crop Protection Ag Herbicidal compositions
TWI882012B (zh) 2019-09-27 2025-05-01 日商武田藥品工業股份有限公司 雜環化合物
CN110981868B (zh) * 2019-11-05 2021-08-31 中山大学 咪唑并吡啶类化合物、包含该化合物的药物组合物及其制备方法和用途
CN113248499A (zh) * 2021-06-07 2021-08-13 中国科学院广州生物医药与健康研究院 一种吲嗪类化合物的制备及应用
WO2023034440A1 (en) 2021-09-01 2023-03-09 Case Western Reserve University Treatment of neurodegenerative diseases with hdac inhibitors

Family Cites Families (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855442A (en) 1988-04-13 1989-08-08 Monsanto Company Substituted 3-hydroxy pyrazoles
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US6794392B1 (en) 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
JPH11269140A (ja) 1998-03-23 1999-10-05 Mitsui Chem Inc 分化誘導剤
JPH11269146A (ja) 1998-03-24 1999-10-05 Mitsui Chem Inc 分化誘導剤
JP4405602B2 (ja) 1998-04-16 2010-01-27 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ヒストン脱アセチル化酵素阻害剤
EP1140834A1 (en) 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Heterocyclic piperidines as modulators of chemokine receptor activity
JP2000256194A (ja) 1999-01-06 2000-09-19 Mitsui Chemicals Inc 核内レセプタ作動薬およびその効果増強剤
AU3676000A (en) 1999-04-09 2000-11-14 Mochida Pharmaceutical Co., Ltd. 4-hydroxypiperidine derivatives having antiarrhythmic effect
EP1748046A3 (en) * 1999-11-23 2007-08-22 Methylgene, Inc. Inhibitors of histone deacetylase
WO2002018335A1 (en) 2000-08-28 2002-03-07 Yamanouchi Pharmaceutical Co., Ltd. Cyclic amine derivatives
EP1390491B1 (en) 2001-05-02 2008-07-16 The Regents of the University of California Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors
US20040142859A1 (en) 2002-05-02 2004-07-22 Steffan Joan S. Method for treating neurodegenerative, psychiatric, and other disorders with deacetylase inhibitors
US6784173B2 (en) 2001-06-15 2004-08-31 Hoffmann-La Roche Inc. Aromatic dicarboxylic acid derivatives
AR034897A1 (es) * 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
US6806272B2 (en) 2001-09-04 2004-10-19 Boehringer Ingelheim Pharma Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US6897220B2 (en) * 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
CN101851173A (zh) * 2001-09-14 2010-10-06 梅特希尔基因公司 组蛋白脱乙酰化酶抑制剂
JP2003137866A (ja) 2001-11-01 2003-05-14 Sankyo Co Ltd フェニレンジアミン誘導体
US7205304B2 (en) 2002-03-13 2007-04-17 Janssen Pharmaceutica N.V. Sulfonyl-Derivatives as novel inhibitors of histone deacetylase
TWI319387B (en) 2002-04-05 2010-01-11 Astrazeneca Ab Benzamide derivatives
GB0209715D0 (en) 2002-04-27 2002-06-05 Astrazeneca Ab Chemical compounds
US20040072770A1 (en) 2002-07-03 2004-04-15 Besterman Jeffrey M. Methods for specifically inhibiting histone deacetylase-7 and 8
JP2004035485A (ja) 2002-07-04 2004-02-05 Mitsui Chemicals Inc テロメラーゼ阻害剤
US20050215601A1 (en) 2002-09-25 2005-09-29 Santen Pharmaceutical Co., Ltd. Therapeutic agent for rheumatic disease comprising benzamide derivative as active ingredient
US7282608B2 (en) 2002-10-17 2007-10-16 Methylgene, Inc. Inhibitors of histone deacetylase
WO2004039318A2 (en) 2002-10-25 2004-05-13 Genesoft Pharmaceuticals, Inc. Anti-infective biaryl compounds
US6852748B1 (en) 2002-10-30 2005-02-08 Boehringer Ingelheim Pharmaceuticals, Inc. Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
TW200426138A (en) 2002-12-10 2004-12-01 Hoffmann La Roche Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives, their manufacture and use as pharmaceutical agents
WO2004058234A2 (en) 2002-12-27 2004-07-15 Schering Aktiengesellschaft Pharmaceutical combinations of phthalazine vegf inhibitors and benzamide hdac inhibitors
US7208491B2 (en) 2003-02-07 2007-04-24 Hoffmann-La Roche Inc. N-monoacylated o-phenylenediamines
AU2004212490B2 (en) 2003-02-10 2008-05-15 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7244751B2 (en) 2003-02-14 2007-07-17 Shenzhen Chipscreen Biosciences Ltd. Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
US7030112B2 (en) 2003-03-25 2006-04-18 Bristol-Myers Squibb Company Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
TW200424187A (en) 2003-04-04 2004-11-16 Hoffmann La Roche New oxime derivatives and their use as pharmaceutically active agents
GB0315203D0 (en) 2003-06-28 2003-08-06 Celltech R&D Ltd Chemical compounds
TWI372050B (en) 2003-07-03 2012-09-11 Astex Therapeutics Ltd (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
WO2005009940A1 (en) 2003-07-24 2005-02-03 Leo Pharma A/S Novel aminobenzophenone compounds
US7868205B2 (en) 2003-09-24 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
US7141596B2 (en) 2003-10-08 2006-11-28 Incyte Corporation Inhibitors of proteins that bind phosphorylated molecules
US9115090B2 (en) 2003-12-02 2015-08-25 The Ohio State University Research Foundation Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors
EP1541549A1 (en) 2003-12-12 2005-06-15 Exonhit Therapeutics S.A. Tricyclic hydroxamate and benzaminde derivatives, compositions and methods
EP1725528B1 (en) 2004-03-11 2013-05-29 4Sc Ag Sulphonylpyrroles as hdac inhibitors
CZ23090U1 (cs) 2004-03-25 2011-12-19 Astellas Pharma Inc. Kompozice pevného farmaceutického prípravku solifenacinu nebo jeho soli
JP5319113B2 (ja) * 2004-03-26 2013-10-16 メチルジーン インコーポレイテッド ヒストンデアセチラーゼの阻害剤
CA2567851A1 (en) 2004-05-21 2006-01-05 Merck & Co., Inc. Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
US20080234254A1 (en) 2004-06-10 2008-09-25 University Of Leeds Inhibitors of Histone Deacetylase
JP2008505964A (ja) 2004-07-12 2008-02-28 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー ヒストン脱アセチル化酵素の阻害剤としてのアミド誘導体
US7625938B2 (en) 2004-07-22 2009-12-01 Merck & Co., Inc. Substituted pyrazoles, compositions containing such compounds and methods of use
AU2005287170B2 (en) 2004-09-17 2012-03-29 Exelixis, Inc Pyrazole kinase modulators and methods of use
JP2008516976A (ja) 2004-10-15 2008-05-22 バイエル・フアーマシユーチカルズ・コーポレーシヨン 抗増殖活性を有するインダンアミド
CN100349070C (zh) 2004-11-25 2007-11-14 同济大学 一种偶氮/酞菁复合单层有机光电导体及其制备方法
WO2006065703A1 (en) 2004-12-13 2006-06-22 Sunesis Pharmaceuticals, Inc. Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors
WO2006066133A2 (en) 2004-12-16 2006-06-22 Takeda San Diego, Inc. Histone deacetylase inhibitors
WO2006070192A1 (en) 2004-12-30 2006-07-06 Astex Therapeutics Limited Thiazole and isothiazole derivatives that modulate the acivity of cdk, gsk and aurora kynases
WO2006097474A1 (en) 2005-03-15 2006-09-21 Nycomed Gmbh N-sulphonylpyrroles and their use as histone deacetylase inhibitors
US20060223807A1 (en) 2005-03-29 2006-10-05 University Of Massachusetts Medical School, A Massachusetts Corporation Therapeutic methods for type I diabetes
US20060264415A1 (en) 2005-04-01 2006-11-23 Methylgene Inc. Inhibitors of histone deacetylase
EP1868994B1 (en) * 2005-04-07 2011-05-25 4Sc Ag Sulfonylpyrroles as histone deacetylase inhibitors
AU2006240258A1 (en) * 2005-04-20 2006-11-02 Merck Sharp & Dohme Corp. Benzothiophene derivatives
JP2008540574A (ja) 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
JP4528918B2 (ja) 2005-06-21 2010-08-25 学校法人 関西大学 カルボキサミド誘導体
CA2612420A1 (en) 2005-06-24 2007-01-04 Merck & Co., Inc. Modified malonate derivatives
AU2006270322A1 (en) 2005-07-14 2007-01-25 Takeda San Diego, Inc. Histone deacetylase inhibitors
KR20080052611A (ko) 2005-08-26 2008-06-11 메틸진 인크. 히스톤 탈아세틸 효소의 벤조디아제핀 및 벤조피페라진유도체 억제제
US20070049603A1 (en) 2005-09-01 2007-03-01 Greg Miknis Raf inhibitor compounds and methods of use thereof
AU2006298881A1 (en) 2005-09-21 2007-04-12 4Sc Ag Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
ATE549333T1 (de) 2005-09-21 2012-03-15 4Sc Ag Neue sulfonylpyrrole als hdac-inhibitoren
US7754773B2 (en) 2005-10-06 2010-07-13 University Of Massachusetts Composition and synthesis of new reagents for inhibition of HIV replication
GB0521244D0 (en) 2005-10-19 2005-11-30 Astrazeneca Ab Benzamide compounds
CA2626898A1 (en) 2005-11-03 2007-05-18 Christopher Hamblett Substituted nicotinamide compounds
JP2009515887A (ja) 2005-11-11 2009-04-16 ザ スクリプス リサーチ インスティテュート 神経系疾患のための治療薬としてのヒストンデアセチラーゼ阻害剤
AR057579A1 (es) 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
US20090012075A1 (en) 2006-01-12 2009-01-08 Miller Thomas A Fluorinated Arylamide Derivatives
EP1973405A4 (en) 2006-01-12 2011-06-01 Merck Sharp & Dohme HYDROXYALKYLARYLAMID DERIVATIVES
WO2007084390A2 (en) 2006-01-13 2007-07-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP1979327A1 (en) 2006-01-19 2008-10-15 Janssen Pharmaceutica, N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
CA2630717C (en) 2006-01-19 2015-02-24 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
CN101370804B (zh) 2006-01-19 2013-05-29 詹森药业有限公司 作为组蛋白脱乙酰基酶抑制剂的新的氨基苯基衍生物
EP1981871B1 (en) 2006-01-19 2011-12-28 Janssen Pharmaceutica N.V. Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
DK1981875T3 (da) 2006-01-19 2014-07-14 Janssen Pharmaceutica Nv Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase
WO2007100657A2 (en) 2006-02-28 2007-09-07 Merck & Co., Inc. Inhibitors of histone deacetylase
GB0606876D0 (en) 2006-04-05 2006-05-17 Glaxo Group Ltd Compounds
KR101495611B1 (ko) 2006-04-07 2015-02-25 메틸진 인코포레이티드 히스톤 데아세틸라아제의 억제제
US8119652B2 (en) 2006-05-18 2012-02-21 Merck Sharp & Dohme Corp. Aryl-fused spirocyclic compounds
GB0614070D0 (en) 2006-07-14 2006-08-23 Glaxo Group Ltd Compounds
US7981874B2 (en) 2006-07-20 2011-07-19 Merck Sharp & Dohme Corp. Phosphorus derivatives as histone deacetylase inhibitors
US8653278B2 (en) 2006-08-03 2014-02-18 Georgetown University Isoform selective HDAC inhibitors
CA2663147A1 (en) 2006-09-11 2008-03-20 Curis, Inc. Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety
US20080221132A1 (en) 2006-09-11 2008-09-11 Xiong Cai Multi-Functional Small Molecules as Anti-Proliferative Agents
WO2008074132A1 (en) 2006-12-19 2008-06-26 Methylgene Inc. Inhibitors of histone deacetylase and prodrugs thereof
JP2008179624A (ja) * 2006-12-26 2008-08-07 Santen Pharmaceut Co Ltd ウレア構造を有する新規ｎ−（２−アミノフェニル）ベンズアミド誘導体
WO2008084218A1 (en) 2007-01-12 2008-07-17 Boehringer Ingelheim International Gmbh Benzazole derivatives for the treatment of inflammations
WO2008089436A2 (en) 2007-01-18 2008-07-24 Takeda San Diego, Inc. Crystalline forms of histone deacetylase inhibitors
US8030344B2 (en) 2007-03-13 2011-10-04 Methylgene Inc. Inhibitors of histone deacetylase
MX2009009786A (es) 2007-03-14 2009-09-24 Exelixis Inc Inhibidores de la via de hedgehog.
CN101730703B (zh) 2007-03-16 2012-12-26 中国人民解放军军事医学科学院放射与辐射医学研究所 具有抗增殖活性的苯甲酰胺类衍生物及其药用制剂
EP2135620A4 (en) 2007-03-28 2010-12-29 Santen Pharmaceutical Co Ltd AGAINST OKULAR HYPOTONIA CONNECTED TO HISTONE DEACETYLASE INHIBITION AS AN ACTIVE SUBSTANCE
WO2008117862A1 (ja) 2007-03-28 2008-10-02 Santen Pharmaceutical Co., Ltd. ウレア構造を有する新規ピリジンカルボン酸（２－アミノフェニル）アミド誘導体
JP5746860B2 (ja) 2007-04-09 2015-07-08 メチルジーン インコーポレイテッド ヒストンデアセチラーゼ阻害剤
US20090005374A1 (en) 2007-06-26 2009-01-01 Melvin Jr Lawrence S Imidazopyridinyl thiazolyl histone deacetylase inhibitors
WO2009002495A1 (en) 2007-06-27 2008-12-31 Merck & Co., Inc. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
EA016888B1 (ru) 2007-06-29 2012-08-30 Пфайзер Инк. Производные бензимидазола
WO2009015237A1 (en) 2007-07-23 2009-01-29 Syndax Pharmaceuticals, Inc. Novel compounds and methods of using them
AU2008284304A1 (en) 2007-08-09 2009-02-12 Merck & Co., Inc. Silicon derivatives as histone deacetylase inhibitors
EP2203171A2 (en) 2007-08-21 2010-07-07 Merck Sharp & Dohme Corp. Cb2 receptor ligands for the treatment of pain
WO2009024825A1 (en) 2007-08-21 2009-02-26 Astrazeneca Ab 2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors
TW200918521A (en) 2007-08-31 2009-05-01 Astrazeneca Ab Heterocyclic amides and methods of use thereof
WO2009036057A1 (en) 2007-09-10 2009-03-19 Curis, Inc. Antiproliferative agents containing a zinc binding moiety
TW200924777A (en) 2007-09-14 2009-06-16 Methylgene Inc Combination therapy
CA2700058A1 (en) 2007-09-19 2009-03-26 4Sc Ag Novel tetrahydrofusedpyridines
ES2628748T3 (es) 2007-10-01 2017-08-03 Lixte Biotechnology, Inc. Inhibidores de la HDAC
BRPI0817860A2 (pt) 2007-10-22 2019-09-24 Orchid Res Laboratories Limited inibidores de histona deacetilase
EP2060565A1 (en) 2007-11-16 2009-05-20 4Sc Ag Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
CA2709068A1 (en) 2007-12-14 2009-06-25 Gilead Colorado, Inc. Benzofuran anilide histone deacetylase inhibitors
WO2009086012A1 (en) 2007-12-20 2009-07-09 Curis, Inc. Aurora inhibitors containing a zinc binding moiety
EP2100882A1 (en) 2008-03-12 2009-09-16 4Sc Ag (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts
CA2729327C (en) 2008-06-27 2016-10-11 Xenon Pharmaceuticals Inc. Heterocyclic derivatives that modulate the activity of stearoyl-coa desaturase
EP2303881A2 (en) 2008-07-14 2011-04-06 Gilead Sciences, Inc. Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases
US8344018B2 (en) 2008-07-14 2013-01-01 Gilead Sciences, Inc. Oxindolyl inhibitor compounds
NZ590283A (en) 2008-07-14 2012-11-30 Gilead Sciences Inc Imidazolylpyrimidine compounds as hdac and / or cdk inhibitors
EP2326622A1 (en) 2008-07-28 2011-06-01 Gilead Sciences, Inc. Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
ES2620027T3 (es) * 2008-09-03 2017-06-27 Biomarin Pharmaceutical Inc. Composiciones que incluyen derivados del ácido 6-aminohexanoico como inhibidores de HDAC
CA2736767A1 (en) 2008-09-05 2010-03-11 Elan Pharmaceuticals, Inc. N-sulfonamido polycyclic pyrazolyl compounds
US8202866B2 (en) 2008-09-17 2012-06-19 Hoffmann-La Roche Inc. Ortho-aminoanilides for the treatment of cancer
TW201016676A (en) 2008-10-03 2010-05-01 Astrazeneca Ab Heterocyclic derivatives and methods of use thereof
WO2010043953A2 (en) 2008-10-15 2010-04-22 Orchid Research Laboratories Ltd. Novel bridged cyclic compounds as histone deacetylase inhibitors
WO2010049182A2 (en) 2008-10-29 2010-05-06 Istituto Superiore Di Sanitá Treatment of retroviral reservoirs exploiting oxidative stress
KR20110117194A (ko) 2009-02-23 2011-10-26 에프. 호프만-라 로슈 아게 암 치료를 위한 신규한 오르토-아미노아미드
KR101145345B1 (ko) 2009-04-24 2012-07-09 계명대학교 산학협력단 세포증식 억제제로서 유용한 2-싸이오-4-아미노 피리미딘 유도체 및 그 제조방법
JP5807971B2 (ja) 2009-04-27 2015-11-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｘｃｒ３受容体アンタゴニスト
US8362249B2 (en) 2009-04-27 2013-01-29 Boehringer Ingelheim International Gmbh CXCR3 receptor antagonists
WO2010127152A2 (en) 2009-04-29 2010-11-04 Irm Llc Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors
EP2429987A4 (en) 2009-05-15 2012-10-03 Korea Res Inst Chem Tech AMIDE COMPOUND, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
US8211901B2 (en) 2009-05-22 2012-07-03 Shenzhen Chipscreen Biosciences Ltd. Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
CA2763786C (en) 2009-06-08 2014-09-30 Gilead Sciences, Inc. Alkanoylamino benzamide aniline hdac inihibitor compounds
EP2440517B1 (en) 2009-06-08 2014-03-26 Gilead Sciences, Inc. Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
CN101648922B (zh) 2009-08-20 2011-08-31 苏州东南药物研发有限责任公司 苯甲酰胺类组蛋白去乙酰酶抑制剂及其用途
US20130210899A1 (en) * 2010-07-30 2013-08-15 The Regents Of The University Of California Method and Therapeutic for the Treatment and Regulation of Memory Formation
CA2828524C (en) 2011-02-28 2020-01-07 Repligen Corporation Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors

Similar Documents

Publication Publication Date Title
JP2014514261A5 (cg-RX-API-DMAC7.html)
AU2018265130B2 (en) Thienopyridines and benzothiophenes useful as IRAK4 inhibitors
ES2209955T3 (es) Derivados de quinolina y su uso como agentes antibacterianos.
ES2512840T3 (es) Derivados de triazol bicíclicos sustituidos novedosos como moduladores de gamma-secretasa
ES2439042T3 (es) Derivados de 5,6,7,8-tetrahidroimidazo[1,2-a]pirazina como moduladores de P2X7
ES2902806T3 (es) Composiciones que contienen compuestos de [1,2,4]triazolo[1,5-a]pirimidin-7-ilo sustituidos como inhibidores de PDE2
RU2018121834A (ru) Новое соединение бифенила или его соль
AU2016384921B2 (en) Crystalline form of BTK kinase inhibitor and preparation method thereof
NZ603896A (en) 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia
ES2615742T3 (es) Benzamidas sustituidas con actividad hacia receptores EP4
KR20090130319A (ko) 스피로인돌리논 유도체
HRP20191364T1 (hr) Sik-inhibitori tipa heteroarila
AU2007219509A1 (en) Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
JPH04210961A (ja) 含窒素多環化合物の製造に有用な中間体
CN112673001B (zh) 作为激酶抑制剂的吲唑甲酰胺
CA2660441A1 (en) Imidazole amines as inhibitors of .beta.-secretase
MX2011000021A (es) Inhibidores de proteina cinasas.
CO6220970A2 (es) Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos
AU2009228649A1 (en) Novel P2X7R antagonists and their use
ES2638317T3 (es) Nuevos derivados de N-(2,3-dihidro-1H-pirrolo[2,3-b]piridin-5-il)-4-quinazolinamina y N-(2,3-dihidro-1H-indol-5-il)-4-quinazolinamina como inhibidores de PERK
ES3047718T3 (en) Cereblon binding compounds, compositions thereof, and methods of treatment therewith
EP3752497A1 (en) P300/cbp hat inhibitors
TW201741303A (zh) 嘧啶類衍生物、其製備方法、其藥物組合物以及其在醫藥上的用途
Zhang et al. A unique one-pot reaction via CC cleavage from aminomethylene benzimidazoles to access benzimidazolones with wide potentiality
Guan et al. New efficient synthesis of 1H-imidazo-[4, 5-c] quinolines by a sequential Van Leusen/Staudinger/aza-Wittig/carbodiimide-mediated cyclization